FIBROGEN INC Logo

FIBROGEN INC

Biopharmaceutical company developing therapeutics for anemia and oncology.

FGEN | US

Overview

Corporate Details

ISIN(s):
US31572Q8087
LEI:
Country:
United States of America
Address:
350 BAY STREET, 94133 SAN FRANCISCO

Description

FibroGen, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company focuses on creating innovative, first-in-class medicines for chronic and life-threatening or debilitating conditions. Its primary areas of research and development are in anemia and oncology. A key product is roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor (HIF) prolyl hydroxylase activity, developed for the treatment of anemia associated with chronic kidney disease. The company's pipeline also includes potential treatments for various cancers, such as pancreatic cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-11-12 20:33 English 9.1 KB
2024-11-04 19:08 English 8.3 KB
2024-11-04 18:11 English 8.4 KB
2024-10-03 22:05
8-K
English 69.1 KB
2024-09-16 22:05
8-K
English 62.1 KB
2024-09-13 22:12
8-K
English 62.2 KB
2024-09-10 02:00 English 6.7 KB
2024-09-10 02:00 English 6.7 KB
2024-09-10 02:00 English 6.6 KB
2024-09-06 22:11
8-K
English 60.8 KB
2024-08-07 23:10
S-8
English 39.2 KB
2024-08-07 23:05
8-K
English 64.7 KB
2024-08-06 22:11
10-Q
English 3.0 MB
2024-08-06 22:05
8-K
English 106.8 KB
2024-08-05 22:18 English 6.7 KB

Automate Your Workflow. Get a real-time feed of all FIBROGEN INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for FIBROGEN INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for FIBROGEN INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.